FUJIFILM Holdings Corporation has launched its “VISION2030” medium-term management plan, emphasizing profitability, capital efficiency, and corporate value enhancement. Under the leadership of Teiichi Goto, president and CEO, the company aims to solidify its stature as a powerhouse of global top-tier businesses. The strategy includes a substantial investment of 1.9 trillion yen to foster growth in sectors like bio-CDMO and semiconductor materials, anticipating significant financial improvements by FY2026 and FY2030.
The plan not only targets financial growth—with an ambitious revenue goal of 4 trillion yen and a 15% operating profit margin by FY2030—but also prioritizes sustainable development. It aligns with Fujifilm’s “Sustainable Value Plan 2030,” focusing on resolving social issues and enhancing environmental and social considerations in business processes.
Key investments will include enhancing the medical diagnostic imaging sector, integrating AI technologies, and expanding the health checkup business. The company will also focus on capital efficiency and innovation in R&D to maintain competitive edges, such as in semiconductor materials and bio-CDMO sectors, marking a shift from investment to profit-making phases post-FY2027.
As Fujifilm marks its 90th anniversary, it continues to innovate and adapt, ensuring its business operations contribute positively to society, aiming to bring ‘more smiles’ across its global stakeholders.
